Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4agu | D15 | Cyclin-dependent kinase-like 1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 1.000 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.489 | |
4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.488 | |
1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.487 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.483 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.480 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.479 | |
1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.475 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.474 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.473 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.472 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.472 | |
4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.471 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.469 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.469 | |
3axw | TID | Casein kinase II subunit alpha | 2.7.11.1 | 0.468 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.467 | |
4ijp | 1EH | Serine/threonine-protein kinase PRP4 homolog | 2.7.11.1 | 0.467 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.463 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.463 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.461 | |
2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.459 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.459 | |
2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.458 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.457 | |
4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.456 | |
5cvf | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
2yaa | ATP | Death-associated protein kinase 2 | / | 0.455 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.455 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.455 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.453 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.450 | |
3c4x | ATP | Rhodopsin kinase | / | 0.450 | |
3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.450 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.450 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.450 | |
4jaj | XU1 | Aurora kinase A | 2.7.11.1 | 0.450 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.450 | |
5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.450 | |
2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
4f08 | 1RS | Tyrosine-protein kinase JAK2 | / | 0.449 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.449 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.447 | |
4qny | ANP | Mitogen activated protein kinase, putative | / | 0.447 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.444 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.444 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.444 | |
3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.444 | |
4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
1jkl | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.443 | |
1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.443 | |
5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.443 | |
2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.442 | |
2ojj | 82A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.440 |